Vaccinex, Inc.
Anti-CD100 antibodies and methods for using the same
Last updated:
Abstract:
Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.
Status:
Grant
Type:
Utility
Filling date:
28 Apr 2017
Issue date:
15 Mar 2022